The Lefkofsky Family foundation is a Chicago-based foundation that strives to improve the quality of life in the areas that they are located in. Liz and Eric Lefkofsky co-founded the foundation in 2006. The purpose of the foundation is to help women, girls, and less fortunate communities stand up for the human rights that they deserve. The foundation also helps to provide a superior education to students, especially those who are in the middle grades. Another focus of the Lefkofsky family foundation is to aid ground-breaking medical research and to develop a variety of other cultural projects.
Eric Lefkofsky is also the co-founder of Tempus. Tempus is a technology company that has gathered all the necessary medical information and has made it available to patients, researchers, and medical professionals. By having this collection of medical and molecular data available, medicine can become more accurate and useful to those who need it.
By using the DNA and RNA through genomic sequencing, physicians can look at tumors at the molecular level and fine tune treatment options for each individual patient. This new type of sequencing has lowered the costs exponentially.
Tempus is also able to extract notes buried in many different reports (oncology, radiation, etc.) and reorganize them. This makes them more readily available to researchers and others who need this information. This organized data makes analysis easier for those who are trying to improve medicine and procedures every day.
Image recognition is another way that Tempus is improve diagnosis and prognosis for patients. By enhancing the quality of images that are produced from radiology scans, medical professionals can better understand the issues that lie beneath the surface. Improved images can also help researchers discover and create new drugs and it also helps them with biomarker development.
Biological Modeling is also helping researchers at Tempus develop new ways to fight cancer. By using tumor organoids, they can learn about more effective ways to fight cancer while still cutting the costs for patients.
The main goal for Lefkofsky and Tempus is to provide better care for each patient by using the information from patients who came before them.